Multicenter retrospective study of response to interferon in chronic hepatitis B;Estudio multicentrico retrospectivo de la respuesta al interferon en la hepatitis cronica por VHB

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 9, 2000, Pages 561-572

  Martin Vivaldi, R ^a   Nogueras, F ^a   Vignote, M L ^a   Salmeron, J ^a   Aguilar, J ^a   Romero, M ^a   Andrade, R ^a   De la Mata, M ^a   Moreno, J M ^a   Perez, J ^a   Garcia, G ^a   Lopez de Hierro, M ^a   Gomez, F ^a   Palacios, A ^a   Otero, S ^a   Suarez, E ^a   Poyatos, A ^a   Quintero, D ^a  

^a NONE   (Spain)

Author keywords

Chronic hepatitis B; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADOLESCENT; ADULT; AGE; ARTICLE; DRUG RESPONSE; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; RELAPSE; SEROCONVERSION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN;

EID: 0033729232     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Antiviral therapy of chronic hepatitis B: Past, present and future
2. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
3. A randomized, controlled trial of a 24-month course of interferon alfa-2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
4. A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B laking HBeAg
5. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B
6. Comparative study of three doses of interferon-α2a in chronic active hepatitis B
7. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B
8. Therapy of acute and chronic viral hepatitis
9. A randomized, controlled trial of recombinant α-interferon therapy for chronic hepatitis B
10. Long- term follow-up of HBeAg-positive patients treated with interferon-alfa for chronic hepatitis B
11. Long-term follow-up of patients with chronic hepatitis B treated with interferon-alfa
12. The treatment of chronic viral hepatitis
13. Interferon therapy for chronic hepatitis B and D: An overview
14. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon
15. Lymphoblastoid interferon-alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial
16. A randomized, controlled trial of recombinant alpha interferon therapy for chronic hepatitis B
17. Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in asian indians: A randomized controlled trial
18. Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B
19. Repeated courses of α-interferon for treatment of chronic hepatitis type B
20. Factores predictivos de respuesta al interferon en la hepatitis cronica
21. Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha
22. Long-term response to interferpon therapy in hepatitis B virus (HBV) pre-C mutants associated chronic hepatitis
23. Natural course and therapy of anti-HBe-positive chronic heatitis B
24. High rate og mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection
25. Hepatitis virus precore/core variation and inteferon therapy
26. Factors predictive of response to interferon therapy in children with chronic hepatitis B
27. Long-term outcome of interferon-alpha therapy for chronic hepatitis B
28. Cost-effectiveness of interferon-α2b treatment for hepatitis B e antigen-positive chronic hepatitis B
29. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa
30. Efecto del interferon-alfa sobre la progresion de la cirrosis a carcinoma hepatocelular: Un estudio de cohorte retrospectivo
31. Interferon treatment in children with chronic hepatitis B
32. Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment
33. Chronic hepatitis B: Problem patients (including patients with decompensated disease)
34. Interferon-alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B
35. Low-dose, titratable interferon-alfa in decompensated liver disease caused by chronic infection with hepatitis B virus